Femara and blood alkaline phosphatase increased Patient Reports February 11, 2012

Femara Side Effects Report #6028979-5
Femara side effect was reported by a Health Professional from FRANCE on Dec 30, 2008. Female patient, weighting 134.5 lb, was diagnosed with neoplasm malignant, tachycardia, hypercholesterolaemia and was treated with Femara. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, blood amylase increased, blood bilirubin increased, diarrhoea. Femara dosage: 2.5 MG, QD. During the same period patient was treated with BISOPROLOL FUMARATE, PRAVASTATIN. Patient recovered.

Femara Side Effects Report #4984164-7
Femara side effect was reported by a Physician from COLOMBIA on Mar 31, 2006. Female patient, 57 years of age, was diagnosed with breast cancer stage iv and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, arthralgia, aspartate aminotransferase increased, blood alkaline phosphatase increased, bone pain, constipation , diarrhoea, gastric cancer. Femara dosage: 2.5 MG/DAY. Patient recovered.

Femara Side Effects Report #4997798-0
Femara side effect was reported by a Physician from COLOMBIA on Mar 31, 2006. Female patient, 57 years of age, was diagnosed with breast cancer stage iv and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, arthralgia, aspartate aminotransferase increased, blood alkaline phosphatase increased, bone pain, constipation , diarrhoea, gastric cancer. Femara dosage: 2.5 MG/DAY. Patient recovered.

Femara Side Effects Report #5802084-2
Femara side effect was reported by a Physician from JAPAN on June 25, 2008. Female patient, weighting 134.5 lb, was diagnosed with breast cancer recurrent, metastases to bone, chronic hepatitis, gastritis, constipation  and was treated with Femara. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood cholesterol increased, blood glucose increased, blood lactate dehydrogenase increased, cardiac failure, dyspnoea, echography abnormal, eosinophil count decreased. Femara dosage: 2.5 MG, QD. During the same period patient was treated with ZOMETA, BARACLUDE, VOLTAREN, OMEPRAL, URSO, MAGMITT KENEI. Patient was hospitalized. Patient recovered.


Femara Side Effects Report #5831736-3
Femara side effect was reported by a Physician from JAPAN on July 23, 2008. Female patient, weighting 134.5 lb, was diagnosed with breast cancer recurrent, metastases to bone, chronic hepatitis, gastritis, constipation  and was treated with Femara. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood cholesterol increased, blood glucose increased, blood lactate dehydrogenase increased, cardiac failure congestive, dyspnoea, echocardiogram abnormal, eosinophil count decreased. Femara dosage: 2.5 MG, QD. During the same period patient was treated with ZOMETA, BARACLUDE, VOLTAREN, OMEPRAL, URSO, MAGMITT KENEI. Patient was hospitalized. Patient recovered.

Femara Side Effects Report #5857152-6
Femara side effect was reported by a Physician from JAPAN on Aug 18, 2008. Female patient, weighting 134.5 lb, was diagnosed with breast cancer recurrent, metastases to bone, chronic hepatitis, gastritis, constipation  and was treated with Femara. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood cholesterol increased, blood glucose increased, blood lactate dehydrogenase increased, cardiac failure congestive, dyspnoea, echocardiogram abnormal, eosinophil count decreased. Femara dosage: 2.5 MG, QD. During the same period patient was treated with ZOMETA, BARACLUDE, VOLTAREN, OMEPRAZOLE, URSO, MAGMITT KENEI. Patient was hospitalized. Patient recovered.

Femara Side Effects Report #4977523-X
Femara side effect was reported by a Physician from COLOMBIA on Mar 31, 2006. Female patient, 57 years of age, was diagnosed with breast cancer female and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, arthralgia, aspartate aminotransferase increased, blood alkaline phosphatase increased, bulimia nervosa, gastric cancer, weight decreased. Femara dosage: 2.5 MG/DAY. Patient recovered.

Femara Side Effects Report #5267003-9
Femara side effect was reported by a Physician from UNITED KINGDOM on Mar 06, 2007. Female patient, 84 years of age, weighting 185.0 lb, was diagnosed with breast cancer , left ventricular failure, reflux gastritis, angina pectoris, constipation  and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood urea increased, bone density decreased, c-reactive protein increased, gamma-glutamyltransferase increased, glomerular filtration rate decreased, liver function test abnormal, lumbar spine flattening. Femara dosage: 2.5MG / DAY. During the same period patient was treated with FRUSEMIDE, OMEPRAZOLE, ISOSORBIDE MONONITRATE, AMLODIPINE, LACTULOSE, SALBUTAMOL. Patient recovered.

Femara Side Effects Report #5278505-3
Femara side effect was reported by a Physician from UNITED KINGDOM on Mar 16, 2007. Female patient, 84 years of age, weighting 185.0 lb, was diagnosed with breast cancer , left ventricular failure, reflux gastritis, angina pectoris, constipation  and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood urea increased, bone density decreased, c-reactive protein increased, gamma-glutamyltransferase increased, glomerular filtration rate decreased, liver function test abnormal, lumbar spine flattening. Femara dosage: 2.5MG / DAY. During the same period patient was treated with FRUSEMIDE, OMEPRAZOLE, ISOSORBIDE MONONITRATE, AMLODIPINE, LACTULOSE, SALBUTAMOL. Patient recovered.


Femara Side Effects Report #4756750-0
Femara side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 12, 2005. Female patient, 74 years of age, was diagnosed with breast cancer , osteoporosis  and was treated with Femara. After drug was administered, patient experienced the following side effects: abdominal pain , arthritis , blood alkaline phosphatase increased, blood calcium increased, blood urine present, bone pain, endometrial disorder, endometrial hyperplasia, fluid retention. Femara dosage: 2.5 MG, QD. During the same period patient was treated with VITAMIN D, CALCITRIOL. Patient was hospitalized. Patient recovered.

Femara Side Effects Report #4806462-X
Femara side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 12, 2005. Female patient, 74 years of age, was diagnosed with breast cancer , osteoporosis  and was treated with Femara. After drug was administered, patient experienced the following side effects: abdominal pain , arthritis , blood alkaline phosphatase increased, blood calcium increased, blood urine present, bone pain, electrocardiogram pr prolongation, endometrial disorder, endometrial hyperplasia. Femara dosage: 2.5 MG, QD. During the same period patient was treated with VITAMIN D, CALCITRIOL. Patient was hospitalized. Patient recovered.

Femara Side Effects Report #4818334-5
Femara side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 12, 2005. Female patient, 74 years of age, was diagnosed with breast cancer , osteoporosis , thyroid disorder and was treated with Femara. After drug was administered, patient experienced the following side effects: abdominal pain , arthritis , blood alkaline phosphatase increased, blood calcium increased, blood urine present, bone pain, electrocardiogram pr prolongation, endometrial disorder, endometrial hyperplasia. Femara dosage: 2.5 MG, QD. During the same period patient was treated with VITAMIN D, CALCITRIOL, SYNTHROID. Patient was hospitalized. Patient recovered.

Femara Side Effects Report #4892247-5
Femara side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 12, 2005. Female patient, 74 years of age, was diagnosed with breast cancer , osteoporosis , thyroid disorder and was treated with Femara. After drug was administered, patient experienced the following side effects: abdominal pain , arthritis , aspartate aminotransferase increased, blood alkaline phosphatase increased, blood calcium increased, blood sodium decreased, blood urine present, bone pain, electrocardiogram pr prolongation. Femara dosage: 2.5 MG, QD. During the same period patient was treated with VITAMIN D, CALCITRIOL, SYNTHROID. Patient was hospitalized. Patient recovered.

Femara Side Effects Report #4724867-2
Femara side effect was reported by a Consumer or non-health professional from UNITED STATES on July 21, 2005. Female patient, 72 years of age, was diagnosed with breast cancer , hypertension and was treated with Femara. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, bone disorder, cholelithiasis. Femara dosage: 2.5 MG, QD. During the same period patient was treated with BISOPROLOL W, SYNTHROID, CALCIUM W. Patient recovered.


Femara Side Effects Report #4731737-2
Femara side effect was reported by a Physician from UNITED STATES on July 21, 2005. Female patient, 72 years of age, was diagnosed with breast cancer , hypertension, hypothyroidism and was treated with Femara. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, bone disorder, cholelithiasis. Femara dosage: unknown. During the same period patient was treated with BISOPROLOL W, SYNTHROID, CALCIUM W, ADVIL. Patient recovered.

Femara Side Effects Report #5553650-3
Femara side effect was reported by a Physician from GERMANY on Dec 05, 2007. Female patient, 66 years of age, was diagnosed with breast cancer , osteoporosis  and was treated with Femara. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, bone density decreased, condition aggravated, lung neoplasm malignant, lung operation, osteoporosis . Femara dosage: unknown. During the same period patient was treated with BISPHOSPHONATES, VITAMIN D, CALCIUM. Patient was hospitalized. Patient recovered.

Femara Side Effects Report #5810924-6
Femara side effect was reported by a Physician from JAPAN on July 07, 2008. Female patient, weighting 110.2 lb, was diagnosed with breast cancer , breast cancer recurrent and was treated with Femara. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, cerebral infarction, dyslalia, dyspnoea, gamma-glutamyltransferase increased, metastases to lung, pericardial drainage. Femara dosage: 2.5 MG/DAY. During the same period patient was treated with FARESTON, LASIX, TOREMIFENE. Patient was hospitalized and became disabled. Patient recovered.

Femara Side Effects Report #5832753-X
Femara side effect was reported by a Physician from JAPAN on July 31, 2008. Female patient, weighting 119.0 lb, was diagnosed with breast cancer , insomnia and was treated with Femara. After drug was administered, patient experienced the following side effects: acidosis, alanine aminotransferase increased, appetite disorder, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased. Femara dosage: 2.5 MG, UNK. During the same period patient was treated with EPIRUBICIN HYDROCHLORIDE, CYCLOPHOSPHAMIDE, MYSLEE, SEROTONE, DEXAMETHASONE PHOSPHATE, PROTECADIN. Patient was hospitalized. Patient died on 05/07/2008.

Femara Side Effects Report #5836483-X
Femara side effect was reported by a Physician from JAPAN on Aug 01, 2008. Female patient, weighting 110.2 lb, was diagnosed with breast cancer , breast cancer recurrent and was treated with Femara. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, cerebral infarction, dyslalia, dyspnoea, gamma-glutamyltransferase increased, metastases to lung, pericardial drainage. Femara dosage: 2.5 MG/DAY. During the same period patient was treated with FARESTON, LASIX, TOREMIFENE. Patient was hospitalized and became disabled. Patient recovered.


Femara Side Effects Report #5838949-5
Femara side effect was reported by a Physician from UNITED STATES on Aug 05, 2008. Female patient was diagnosed with breast cancer , neoplasm malignant, neoplasm progression and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atrial fibrillation , blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood calcium decreased, blood glucose increased, blood magnesium increased. Femara dosage: 2.5 MG, QD. During the same period patient was treated with ZOMETA, FULVESTRANT, NAVELBINE, HERCEPTIN, ALBUTEROL, ADRIAMYCIN PFS, CYCLOPHOSPHAMIDE, OXYGEN. Patient died.

Femara Side Effects Report #5840714-X
Femara side effect was reported by a Physician from JAPAN on Aug 06, 2008. Female patient, weighting 119.0 lb, was diagnosed with breast cancer , insomnia and was treated with Femara. After drug was administered, patient experienced the following side effects: acidosis, alanine aminotransferase increased, appetite disorder, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased. Femara dosage: 2.5 MG, UNK. During the same period patient was treated with EPIRUBICIN HYDROCHLORIDE, CYCLOPHOSPHAMIDE, MYSLEE, SEROTONE, DEXAMETHASONE PHOSPHATE, PROTECADIN. Patient was hospitalized. Patient died on 05/07/2008.

Femara Side Effects Report #5863434-4
Femara side effect was reported by a Physician from JAPAN on Aug 25, 2008. Female patient, weighting 119.0 lb, was diagnosed with breast cancer , insomnia and was treated with Femara. After drug was administered, patient experienced the following side effects: acidosis, alanine aminotransferase increased, appetite disorder, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased. Femara dosage: 2.5 MG, UNK. During the same period patient was treated with EPIRUBICIN HYDROCHLORIDE, CYCLOPHOSPHAMIDE, MYSLEE, SEROTONE, DEXAMETHASONE PHOSPHATE, PROTECADIN. Patient was hospitalized. Patient died on 05/07/2008.

Femara Side Effects Report #5907269-2
Femara side effect was reported by a Physician from JAPAN on Sept 29, 2008. Female patient, weighting 119.0 lb, was diagnosed with breast cancer , insomnia and was treated with Femara. After drug was administered, patient experienced the following side effects: acidosis, alanine aminotransferase increased, appetite disorder, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased. Femara dosage: 2.5 MG, UNK. During the same period patient was treated with FARMORUBICIN, CYCLOPHOSPHAMIDE, MYSLEE, SEROTONE, DEXAMETHASONE PHOSPHATE, PROTECADIN. Patient was hospitalized. Patient died on 05/07/2008.

Femara Side Effects Report #5815988-1
Femara side effect was reported by a Consumer or non-health professional from SWITZERLAND on July 11, 2008. Female patient, 59 years of age, was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, cholestasis, gamma-glutamyltransferase increased, transaminases increased. Femara dosage: 2.5 MG/DAY. Patient recovered.